References
- Kyle R. A. Newer approaches to the management of multiple myeloma. Cancer 1993; 72: 3489–3494
- Mills K. H. G., Cawley J. C. Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma. Brit J Hemat 1983; 53: 271–275
- San Miguel J. F., Caballero M. D., Gonzalez M. Subpopulations in patients with monoclonal gammopathies: Essential monoclonal gammopathy, multiple myeloma, and Waldenstroms macroglobulinemia. Amer J Hemat 1985; 20: 267–273
- Serra H. M., Mant M. J., Ruether B. A., Ledbetter J. A., Pilarski L. M. Selective loss of CF4+, CD45R+T cells in peripheral blood of multiple myeloma patients. J Clin Immunol 1988; 8: 259–264
- Pilarski L. M., Andrews E. J., Serra H. M., et al. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Amer J Hemat 1989; 30: 53–60
- Hoover R. G., Kornbluth J. Immunoregulation of murine and human myeloma. Hemat Oncol (N. A.) 1992; 6((supplement 2))407–424
- Zaknoen S. L., Kay N. E. Immunoregulatory cell dysfunction in chronic B-cell leukemias. Blood Revs 1990; 4: 165–174
- Wen T., Mellstedt A., Jondal M. Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma. J Exp Med 1990; 171: 659–664
- Janson C. H., Gruenwald J., Osterborg A. Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. Blood 1991; 77: 1776–1780
- Kay N. E., Oken M. M., Kyle R. A. Detection of clonal blood T cell populations in multiple myeloma patients. Blood 1993; 82((supplement 1))258a
- Moss P. A., Gillespie G., Frodsham P., Bell J. I. Clonal populations of CD4 and CDS T cells in patients with paraprotinemia and myeloma. Blood 1994; 84((supplement))177a
- Clark S. P., Yoshikai Y., Siu G. Identification of a diversity segment ofthe human T cell receptor β chain, and comparison to the analogous murine element. Nature 1994; 311: 387
- Hood L., Kronenberg M., Hunkapiller. T cell antigen receptors and the immunoglobulin supergene family. Cell 1985; 40: 225
- Moss P. A. H., Rosenburg W. M. C., Bell J. The human T cell receptor in health and disease. Ann Rev Immunol, 10: 71–96
- Jorgensen J., Reay P., Ehrich E. W., Davis M. M. Molecular components of T cell recognition. Ann Rev Immunol 1992; 10: 835
- Metis L. A. The molecular basis of T cell specificity. Ann Rev Immunol 1990; 8: 65
- Dune B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842–854
- Lehmann E. L. Nonparametrics: Statistical Methods Based on Ranks. Holden-Day, Berkley, CA 1975
- Mokyr M. B., Rubin M., Newell K. A. Involvement of TCR-Vβ8.3+ cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan. J Immunol 1993; 151: 4838–4846
- Scott P., Kaufmann S. H. E. The role of T cell subsets and cytokines in the regulation of infection. Immunol Today 1991; 12: 346–348
- Swain S. L., Bradley L. M., Croft M. Helper T cell subsets: phenotype function and the role of lymphokines in regulating their development. Immunol Rev 1991; 123: 115–144
- Kay N. E., Bone N., Leong T, Oken M. M., Kyle R. A., Greipp P. R., Van Ness B. T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93. Brit J Haemal 1998; 100: 459–463
- Farace F., Orlanducci F., Dietrich P. Y., et al. T cell repertoire in patients with chronic B cell lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol 1994; 153: 4281
- Mackensen A. G., Carcelain G., Viel S., et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Investigation 1993; 93: 1397